INFUSYSTEM HOLDINGS, INC Total Long-Term Debt
INFUSYSTEM HOLDINGS, INC (INFU) had Total Long-Term Debt of $20.42 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2026-08-04
- 2026-06-30: Long-term Debt $20.42M.
- 2026-03-31: Long-term Debt $19.65M.
- 2025-12-31: Long-term Debt $19.63M.
- 2025-09-30: Long-term Debt $20.93M.
| Period end | Long-term Debt |
|---|---|
| 2026-06-30 | $20.42M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $19.65M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $19.63M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $20.93M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $26.35M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $28.71M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $23.86M 10-K · filed 2026-02-27 |
| 2024-09-30 | $27.98M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $34.16M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $29.93M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $29.10M 10-K · filed 2025-03-11 |
| 2023-09-30 | $32.66M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $36.14M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $36.39M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $33.16M 10-K · filed 2024-04-10 |
| 2022-09-30 | $34.46M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $33.69M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $34.95M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $33.10M 10-K · filed 2023-03-16 |
| 2021-09-30 | $30.89M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $32.46M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $32.42M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $38.80M 10-K · filed 2022-03-15 |
| 2020-09-30 | $34.79M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $40.87M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $39.62M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $38.38M 10-K · filed 2021-03-22 |
| 2019-09-30 | $37.35M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $33.56M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $32.86M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $33.74M 10-K · filed 2020-03-30 |
| 2018-09-30 | $33.44M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $25.00M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $25.76M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $28.39M 10-K · filed 2019-03-22 |
| 2017-09-30 | $29.38M 10-Q · filed 2017-11-13 |
| 2017-06-30 | $31.38M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $30.37M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $31.89M 10-K · filed 2018-03-19 |
| 2016-09-30 | $38.64M 10-Q · filed 2016-12-12 |
| 2016-06-30 | $39.42M 10-Q/A · filed 2016-12-12 |
| 2016-03-31 | $37.61M 10-Q/A · filed 2016-12-12 |
| 2015-12-31 | $34.94M 10-K/A · filed 2016-12-12 |
| 2015-09-30 | $35.23M 10-Q · filed 2015-11-12 |
| 2015-06-30 | $34.78M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $33.62M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $25.48M 10-K/A · filed 2016-12-12 |
| 2014-09-30 | $27.87M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $26.70M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $27.17M 10-Q · filed 2014-05-05 |
| 2013-12-31 | $26.73M 10-K · filed 2015-03-09 |
| 2013-09-30 | $27.62M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $28.33M 10-Q · filed 2013-08-13 |
| 2012-12-31 | $31.27M 10-K · filed 2014-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |